About this trial
This research project is a randomized cross-over pilot trial which aims to test the efficacy of N-acetylcysteine (NAC) for the treatment of Repetitive Behaviors (RB) and self-injurious behavior (SIB) in patients with Cornelia de Lange Syndrome (CdLs).
NAC is a known anti-oxidative stress and neuroprotective agent, which has been shown to decrease the occurrence of SIB such as skin picking. NAC has also shown partial response in trials for compulsive behaviors in Obsessive Compulsive Disorder (OCD) and related disorders in autism.
Cornelia de Lange syndrome (CdLS) is a genetic disorder with autistic features, including RBs and SIB. In this randomized clinical trial, participants with CdLS will be blindly assigned one of two possible treatment arms: 1) placebo (8 weeks) and NAC (8 weeks); or 2) NAC (8 weeks) and placebo (8 weeks), with an intermediate 2-week washout period.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Ages 13 to 35 years
A diagnosis of CdLS as determined by a physician during routine care meeting the major and minor criteria from CdLS guidelines
Threshold criteria for the presence of RB/SIB as reported on initial screening Children's Yale-Brown Obsessive Compulsive Scale Modified for Pervasive Developmental Disorders (CYBOCS-PDD) > 6 OR Aberrant Behavior Checklist (ABC) stereotypy subscale > 7)
Being able to attend 4 visits over the course of 18 weeks at the Johns Hopkins Hospital
Disqualifiers
Allergy to NAC
Allergy to Quinine
Contraindication to NAC (organ transplant; untreated or symptomatic gastric condition)
Need for another medication with which NAC is contraindicated (antibiotics)
Trial design
Crossover
Treatments tested in this trial
N-acetyl cysteine
DrugOral solution for N-acetyl cysteine is prepared in syringes and provided to the participants along with instructions on how to administer them.
Placebo
Other interventionNAC Placebo-matching solution is prepared in syringes and provided to the participants along with instructions on how to administer them.
Treatment groups
Trial outcomes
Primary outcomes
Change in Children's Yale-Brown Obsessive Compulsive Scale Modified for Pervasive Developmental Disorders (CYBOCS-PDD) repetitive behaviors measure score
CYBOCS-PDD scores range from a minimum of 0 to a maximum of 20, higher scores indicate greater symptom severity. Efficacy of the intervention would be assessed by ≥35% reduction in CYBOCS-PDD repetitive behaviors measure score.
Change in Aberrant Behavior Checklist (ABC) irritability self-injurious behaviors items score
The ABC irritability sub-scale consists of 15 items of which 3 focus on Self-injurious Behaviors (SIB). Each item takes scores ranging from a minimum of 0 to a maximum of 3. The overall score for the SIB items would range from 0 to 9 with higher scores indicating greater symptom severity. Efficacy of the intervention in reducing self-injurious behaviors would be assessed by a ≥35% reduction in ABC irritability SIB items sub-scale score.
Secondary outcomes
Change in Aberrant Behavior Checklist (ABC) irritability non-injurious behaviors items score
The ABC irritability sub-scale consists of 15 items of which 12 focus on depressed mood and irritable behaviors (non-injurious behaviors). Each item takes a score ranging from a minimum of 0 to a maximum of 3. The overall score for the non-injurious behavior items would range from 0 to 36 with higher scores indicating greater symptom severity. Efficacy of the intervention in reducing depressed mood and irritability would be assessed by a ≥35% score reduction in ABC irritability non-injurious behavior items of sub-scale.
Change in total score of Parenting Stress Index/Short Form (PSI/SF)
The PSI-SF is a 36-item questionnaire designed to measure stress in the parent-child system and identify those families most in need of follow-up services. The PSI-SF consists of three sub-scales: Parental Distress, Parent-Child Dysfunctional Interaction, and Difficult Child. Each sub-scale consists of 12 items rated from 1 (strongly disagree) to 5 (strongly agree). Sub-scale scores therefore range from 12 to 60, whereas the total score ranges from 36 to 180. High scores on the PSI-SF total score indicate greater levels of stress.
Change in Burden Scale for Family Caregivers score
Burden Scale for Family Caregivers, for assessing subjective burden in informal caregivers. It consists of 10 items, each ranging from 0 to 3, with total score ranging from 0 to 30. High scores indicate greater levels of burden in caregiver.
Change in Sensory Profile score
Sensory profile measure identifies sub-types of individuals based on sensory processing patterns and categorize it as one of the following five profiles: 1- Balanced; 2- Interested; 3- Intense; 4- Mellow until ... ; and 5- Vigilant.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Johns Hopkins University
Lead sponsor
Cornelia de Lange Syndrome Foundation
Collaborator
This trial is not recruiting at the moment. You can still explore other options: